CONMED (CNMD) PT Raised to $45 at Piper Sandler
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $45.72 -0.09%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 27 | New: 16
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 27 | New: 16
Join SI Premium – FREE
Piper Sandler analyst Matt O'Brien raised the price target on CONMED (NYSE: CNMD) to $45.00 (from $39.00) while maintaining a Neutral rating.
You May Also Be Interested In
- CONMED (CNMD) PT Raised to $50 at JPMorgan
- Churchill Downs (CHDN) PT Lowered to $131 at Stifel, Stays on Stifel Select List
- Ligand Pharma (LGND) PT Raised to $350 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
